The Rev. Daniel H. Grossoehme, an Episcopal priest and staff chaplain at Cincinnati Children's Hospital Medical Center since 2003, has been awarded a research grant from the National Institutes of Health, according to a press release.
Grossoehme, a board certified chaplain since 1997, received the five-year, $590,000 grant to conduct research on improving parental adherence to recommended home treatments for cystic fibrosis. He is the second chaplain in the U.S. ever to receive an NIH research grant.
"Our goal is to integrate spirituality into an already existing behavioral model of adherence, and to understand how parents' spirituality impacts their adherence intentions and behaviors," said Grossoehme, according to the release. "This is important because this understanding will enable us to improve existing adherence interventions and thus child health outcomes."
Cystic fibrosis, the release explains, is "an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States (70,000 worldwide). A defective gene and its protein product cause the body to produce unusually thick, sticky mucus that clogs the lungs and leads to life-threatening lung infections; and obstructs the pancreas and stops natural enzymes from helping the body break down and absorb food."
While much is known about factors affecting adherence, less is known about the role of other factors, such as spirituality, the release noted.
Grossoehme completed his clinical pastoral residency at the Cleveland Clinic Foundation Hospital with an emphasis in pediatrics and critical care in 1992-1993. He became the first director of chaplaincy services at Children's Hospital Medical Center of Akron, where he served from 1993 to 2003.